Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Klein

Showing results (341-350 of 379) with videos related to

Pageof 38
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter studyFelix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Neurological Research and Practice|June 28, 2021
Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from GermanyJohann Philipp Zöllner, Nadine Conradi, Matthias Sauter, et al.
BMC Neurology|January 13, 2024
Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocolPauline T Waskowiak, Brigit A de Jong, Bernard M J Uitdehaag, et al.
Epilepsia|June 28, 2019
A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in GermanyAdam Strzelczyk, Susanne Schubert-Bast, Thomas Bast, et al.
Cannabis and Cannabinoid Research|July 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-AnalysisVera Belgers, Jantine G Röttgering, Linda Douw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 26, 2021
Cellular Substrates of Functional Network Integration and Memory in Temporal Lobe EpilepsyLinda Douw, Ida A Nissen, Sophie M D D Fitzsimmons, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
Neuro-Oncology|July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study designKurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Pageof 38

Showing results (341-350 of 379) with videos related to

Sort By:
Pageof 38
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter studyFelix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Neurological Research and Practice|June 28, 2021
Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from GermanyJohann Philipp Zöllner, Nadine Conradi, Matthias Sauter, et al.
BMC Neurology|January 13, 2024
Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocolPauline T Waskowiak, Brigit A de Jong, Bernard M J Uitdehaag, et al.
Epilepsia|June 28, 2019
A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in GermanyAdam Strzelczyk, Susanne Schubert-Bast, Thomas Bast, et al.
Cannabis and Cannabinoid Research|July 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-AnalysisVera Belgers, Jantine G Röttgering, Linda Douw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 26, 2021
Cellular Substrates of Functional Network Integration and Memory in Temporal Lobe EpilepsyLinda Douw, Ida A Nissen, Sophie M D D Fitzsimmons, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
Neuro-Oncology|July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study designKurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Pageof 38